Home
Conditions
Hemic and Lymphatic Diseases

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,120 public trials 3,997 recruiting studies

Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

NCT03670966

Conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, +37 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A

NCT06222697

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: Many Locations Multiple Locations, South Korea

View Trial Details

Recruiting

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

NCT05156983

Conditions: Cardiovascular Diseases, Coagulation Disorder, Hematologic Diseases, +4 more
Locations: University of Arkansas Medical Sciences Arkansas City, Arkansas, United States

University of California Davis Health System Sacramento, California, United States

Denver Metro Orthopedics, P.C. Englewood, Colorado, United States

University of Florida Gainesville, Florida, United States

View all 64 locations

View Trial Details

Recruiting

Evaluation of Skin Tests in Biotherapy Allergies

NCT06971848

Conditions: AL Amyloidosis, Adenocarcinoma, Adenoma, +75 more
Locations: CHU Angers Angers, France

View Trial Details

Recruiting

Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP

NCT07656909

Conditions: Blood Platelet Disorders, Cytopenia, Hemangioma, +10 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

NCT04093986

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Recruiting

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

NCT06579469

Conditions: B-ALL, Hematologic Diseases, Hematologic Malignancy, +5 more
Locations: Childrens Hospital of Colorado Aurora, Colorado, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

Primary Children's Hospital Salt Lake City, Utah, United States

View Trial Details

Recruiting

Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia

NCT07657793

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +20 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Ivosidenib as Post-HSCT Maintenance for AML

NCT06707493

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hematopoietic Stem Cell Transplant (HSCT), +7 more
Locations: Emory University Hospital Atlanta, Georgia, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Ohio State University Wexner Medical Center- James Cancer Hospital Columbus, Ohio, United States

View Trial Details

Recruiting

Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission

NCT07507318

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Hemic and Lymphatic Diseases

Hemic and Lymphatic Diseases trial results

Related conditions